Replies to post #321972 on Avid Bioservices Inc (CDMO)

[biopharm]

Thanks Hutschi and am going to post this below re: BGB324 and to help me keep track of a long list of names affiliated as Dr. Rolf Brekken and many others ....

Richard Godfrey, Chief Executive Officer of BerGenBio, commented:

"This promising new preclinical data demonstrates the rationale for combining BGB324 with immune checkpoint inhibitors to treat aggressive cancer. In addition to the ongoing development of BGB324 in AML and NSCLC, this data suggests that BGB324 could also be used in combination with cancer immunotherapeutic agents to enhance their efficiency."

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120429626